Pharsight shareholders to decide merger with Tripos Oct. 27

By Lisa Kerner

Charlotte, N.C., Oct. 1 - Pharsight Corp. will hold a special meeting of stockholders at 1 p.m. ET on Oct. 27, it was reported in a schedule 14A filed with the Securities and Exchange Commission.

Shareholders as of the Sept. 30 record date will be asked to approve the company's merger with Tripos, Inc.

Pharsight's board of directors believes the merger is in the best interests of the company and its stockholders, the filing said.

It was previously reported that Tripos agreed to acquire Pharsight for $5.50 per share, or $57 million in cash.

Pharsight is a Mountain View, Calif., pharmaceutical software company.

Tripos provides drug discovery informatics products and services. The company is located in St. Louis and is wholly owned by Vector Capital.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.